Corvus Pharmaceuticals Inc.
CRVS | NASDAQ
$13.17
+$0.75 (+6.04%)
Sep 22, 2026, 1:04 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -67.82M | -44.17M | -15.28M | -15.08M | -45.14M | -41.4M | -62.29M | -56.83M | -22.62M | -24.86M | -27.03M | -30.19M | -39.02M | -40.88M | -41.31M | -40.73M | -36.57M | -39.96M | -43.24M | -6.66M | -5.78M | -4.64M |
Depreciation & Amortization | 146K | 112K | 105K | 99K | 92K | 84K | 85K | 93K | 102K | 117K | 151K | 217K | 281K | 337K | 367K | 366K | 380K | 410K | 460K | 509K | 548K | 585K |
Stock-Based Compensation | 10.73M | 6.73M | 5.33M | 4.6M | 4.05M | 3.57M | 3M | 2.73M | 2.58M | 2.34M | 2.15M | 2.2M | 2.31M | 2.45M | 2.69M | 2.81M | 3.25M | 3.75M | 4.23M | 4.73M | 4.92M | 5.13M |
Other Working Capital | -5.11M | 59K | 3.63M | 897K | 39K | -1.17M | -2.47M | -801K | -427K | -1.73M | -3.71M | -3.75M | -1.02M | 45K | 1.08M | 1.58M | -1.12M | -1.43M | -827K | -1.5M | -869K | -26K |
Other Non-Cash Items | 3.96M | -1.07M | -26.53M | -22.73M | 10.25M | 10.75M | 35.24M | 32.28M | 47K | 2.54M | 4.39M | 7.55M | 9.57M | 10.18M | 9.81M | 7.97M | 7.07M | 5.97M | 5.07M | -34.64M | -36.27M | -36.81M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -1.92M | 3.48M | 3.58M | 1.04M | 1.91M | -1.53M | -1.46M | -391K | -1.35M | -1.12M | -3.59M | -6.08M | -949K | -793K | 1.41M | 3.25M | -1.96M | -4.52M | -3.24M | -2.01M | -786K | 1.53M |
Operating Cash Flow | -54.9M | -34.91M | -32.8M | -32.07M | -28.83M | -28.53M | -25.42M | -22.13M | -21.24M | -20.98M | -23.94M | -26.32M | -27.81M | -28.71M | -27.02M | -26.33M | -27.83M | -34.35M | -36.72M | -38.07M | -37.37M | -34.21M |
Capital Expenditures | -789K | -229K | -174K | -149K | -149K | -36K | n/a | n/a | n/a | n/a | -34K | -38K | -303K | -307K | -273K | -274K | -9K | -5K | -5K | n/a | -76K | -76K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 22K | 22K | 18.86K | 18.86K | -3.14K | -3.14K | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -420.78M | -245.78M | -91.75M | -98.69M | -86.38M | -73.2M | -70.12M | -61.18M | -44.16M | -38.59M | -47.05M | -54.92M | -70.58M | -52.9M | -66.19M | -51.38M | -34.07M | -32.42M | -9.36M | -11.94M | -17.52M | -34.45M |
Sales Maturities Of Investments | 134.18M | 89.12M | 84.13M | 74.08M | 60.49M | 50M | 42.63M | 37.46M | 41.88M | 49.52M | 62.62M | 68.91M | 70.33M | 60.08M | 43.16M | 30.27M | 13.12M | 23.57M | 30.92M | 35.96M | 48.08M | 56.44M |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 4K | 4K | 7.14K | 7.14K | 3.14K | 3.14K | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -287.4M | -156.89M | -7.8M | -24.76M | -26.03M | -23.23M | -27.48M | -23.72M | -2.28M | 10.93M | 15.54M | 13.98M | -529K | 6.9M | -23.28M | -21.39M | -20.96M | -8.86M | 21.56M | 24.02M | 30.49M | 21.92M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 8K | 7.52M | 7.53M | 7.53M | 7.52M | 4K | n/a | n/a | 1.2M | 1.2M | 1.2M | 2.42M | 1.22M | 1.25M |
Financial Cash Flow | 382.04M | 226.9M | 36.43M | 55.02M | 54.71M | 49.31M | 49.03M | 30.42M | 30.71M | 7.85M | 7.86M | 7.86M | 7.52M | 4K | n/a | 18K | 18.35M | 29.57M | 62.16M | 63.36M | 45.09M | 33.9M |
Net Cash Flow | 39.74M | 35.1M | -4.16M | -1.81M | -150K | -2.46M | -3.88M | -15.43M | 7.18M | -2.2M | -539K | -4.48M | -20.82M | -21.81M | -50.3M | -47.71M | -30.44M | -13.64M | 47M | 49.32M | 38.21M | 21.61M |
Free Cash Flow | -55.69M | -35.14M | -32.97M | -32.22M | -28.98M | -28.57M | -25.42M | -22.13M | -21.24M | -20.98M | -23.97M | -26.35M | -28.11M | -29.02M | -27.3M | -26.61M | -27.84M | -34.36M | -36.72M | -38.07M | -37.45M | -34.29M |
Adj. Free Cash Flow | -66.42M | -41.87M | -38.3M | -36.82M | -33.03M | -32.13M | -28.43M | -24.86M | -23.81M | -23.33M | -26.12M | -28.55M | -30.42M | -31.46M | -29.99M | -29.42M | -31.09M | -38.1M | -40.95M | -42.8M | -42.37M | -39.42M |
Maintenance CapEx | -117K | -83K | -76K | -51K | -51K | -22K | n/a | n/a | n/a | n/a | -34K | -38K | -132K | -136K | -102K | -103K | -9K | -5K | -5K | n/a | -76K | -76K |
Growth CapEx | -672K | -146K | -98K | -98K | -98K | -14K | n/a | n/a | n/a | n/a | n/a | n/a | -171K | -171K | -171K | -171K | n/a | n/a | n/a | n/a | n/a | n/a |
Owner Earnings | -55.02M | -34.99M | -32.87M | -32.12M | -28.88M | -28.55M | -25.42M | -22.13M | -21.24M | -20.98M | -23.97M | -26.35M | -27.94M | -28.85M | -27.13M | -26.44M | -27.84M | -34.36M | -36.72M | -38.07M | -37.45M | -34.29M |
Add to Watchlist
Select watchlists to add or remove CRVS